Amgen Recalls Anemia Medications Epogen and Procrit Over Glass Fragments
Drug-makers Amgen and Johnson & Johnson are voluntarily recalling two brands of an injectable anemia medication because of the possibility that vials of it may also contain tiny glass flakes. The drug, Epoetin alfa, is marketed under the brand names Epogen and Procrit. Continue reading Amgen Recalls Anemia Medications Epogen and Procrit Over Glass Fragments Amgen Recalls Anemia Medications Epogen and Procrit Over Glass Fragments originally appeared on DailyFinance on Fri, 24 Sep 2010 11:55:00. Filed Under: Company News , Health Care , Johnson & Johnson , Amgen Permalink | Tweet this! | Comments
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here